- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00790166
Effects of Humidity (During CPAP Treatment) on Mucociliary Clearance in Patients With Obstructive Sleep Apnea (CIA-6)
April 25, 2018 updated by: Fisher and Paykel Healthcare
Effects of nCPAP With and Without Humidification on: Inspiratory Temperature, Humidity, Saccharine Transit Time, Nasal Lavage and in Vitro Mucus Properties in Patients With Obstructive Sleep Apnea
That the level of humidification delivered to patients during CPAP treatment will alter the subjects mucociliary clearance rate and related mucus properties.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sao Paulo, Brazil
- Faculty of Medicine: Pulmonology: University of Sao Paulo Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Moderate to severe obstructive sleep apnea - Apnea Hypopnea Index (AHI) > 15
- 75% of events during the diagnostic study must be obstructive
Exclusion Criteria:
- Currently using CPAP treatment OR have used it in the past 4 weeks
- Intolerance of CPAP and/or CPAP mask in the past or during the titration night
- Mouth breather (unable to breath through mouth for the study period)
- < 18years old
- Nasal CPAP intolerance determined in the PSG-CPAP titration study
- Serious nasal issues
- Acute upper airway disease
- Smoker
- COPD
- Congestive heart failure
- Neuromuscular disease
- Stroke
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: CPAP + ThermoSmart™ humidity
|
an absolute humidity (AH) of 28 mg/l +/- 2mg/l
|
|
Active Comparator: CPAP + Conventional humidity
|
an absolute humidity (AH) of 18 mg/l +/- 2 mg/l
|
|
Active Comparator: CPAP + No added humidity
|
ambient humidity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
mucociliary clearance.
Time Frame: pre and post cpap treatment with varying levels of humidity
|
pre and post cpap treatment with varying levels of humidity
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Geraldo Lorenzi, MD, Faculty of Medicine: Pulmonology: University of Sao Paulo Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2008
Primary Completion (Actual)
June 24, 2009
Study Completion (Actual)
June 24, 2009
Study Registration Dates
First Submitted
November 11, 2008
First Submitted That Met QC Criteria
November 11, 2008
First Posted (Estimate)
November 13, 2008
Study Record Updates
Last Update Posted (Actual)
April 27, 2018
Last Update Submitted That Met QC Criteria
April 25, 2018
Last Verified
June 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OSA CPAP,ThemoSmartMCC, Brasil
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.